Starting Dose of Strattera (Atomoxetine)
For adults and adolescents over 70 kg, start atomoxetine at 40 mg orally once daily; for children and adolescents up to 70 kg, start at approximately 0.5 mg/kg/day. 1
Dosing for Children and Adolescents (≤70 kg)
- Initial dose: 0.5 mg/kg/day, administered either as a single morning dose or divided into morning and late afternoon/early evening doses 1
- Titration schedule: Increase after a minimum of 3 days to a target dose of approximately 1.2 mg/kg/day 1
- Maximum dose: Do not exceed 1.4 mg/kg/day or 100 mg total daily dose, whichever is less 1
- Children weighing less than 25 kg generally should not receive single doses greater than 15 mg 2
Dosing for Adolescents (>70 kg) and Adults
- Initial dose: 40 mg once daily 1, 2
- Titration schedule: Increase after a minimum of 3 days to a target dose of 80 mg/day, administered either as a single morning dose or divided doses 1
- Further titration: After 2-4 additional weeks, may increase to maximum of 100 mg/day in patients without optimal response 1
- Typical titration pattern: Adjust every 7-14 days from 40 mg to 60 mg, then to 80 mg/day 2
- Maximum dose: 100 mg/day or 1.4 mg/kg/day, whichever is less 2, 1
Administration Guidelines
- Atomoxetine may be taken with or without food 1
- Capsules should be swallowed whole and not opened 1
- Can be discontinued without tapering 1
- May be administered once daily in the morning or split into two evenly divided doses (morning and late afternoon/early evening) 1
Special Population Dosing Adjustments
Hepatic Impairment
- Moderate hepatic insufficiency (Child-Pugh Class B): Reduce initial and target doses to 50% of normal dose 1
- Severe hepatic insufficiency (Child-Pugh Class C): Reduce initial and target doses to 25% of normal dose 1
CYP2D6 Poor Metabolizers or Concurrent Strong CYP2D6 Inhibitors
For children/adolescents ≤70 kg:
- Start at 0.5 mg/kg/day 1
- Only increase to usual target of 1.2 mg/kg/day if symptoms fail to improve after 4 weeks and initial dose is well tolerated 1
For adolescents >70 kg and adults:
- Start at 40 mg/day 1
- Only increase to usual target of 80 mg/day if symptoms fail to improve after 4 weeks and initial dose is well tolerated 1
- This applies when using strong CYP2D6 inhibitors such as paroxetine, fluoxetine, or quinidine 1
Important Pre-Treatment Considerations
- Screen for personal or family history of bipolar disorder, mania, or hypomania before initiating treatment 1
- Obtain baseline blood pressure, pulse, height, and weight in context of physical examination 2
- Document prior treatments including previous medications, dosages, duration, response, and side effects 2
Common Pitfalls to Avoid
- Do not exceed maximum doses: The safety of single doses over 120 mg and total daily doses above 150 mg have not been systematically evaluated 1
- Avoid rapid titration: Minimum 3-day intervals between dose increases are required to assess tolerability 1
- Do not open capsules: Atomoxetine must be swallowed whole 1
- Monitor for early adverse effects: Initial somnolence and gastrointestinal symptoms can occur, particularly if dose is increased too rapidly 3